FFPE Archives | Page 63 of 85 | NanoString

Home » FFPE » Page 63

December 19, 2019 / Trials

Pharmacodynamics of Pre-Operative PD1 checkpoint blockade and receptor activator of NFkB ligand (RANKL) inhibition in non-small cell lung cancer (NSCLC): study protocol for a multicentre, open-label, phase 1B/2, translational trial (POPCORN)

Ahern E et al.,

December 17, 2019 / Front Oncol

Precision Medicine in Lymphoma by Innovative Instrumental Platforms

Di Paolo A et al.,

December 12, 2019 / JCI Insight

Immunologic alterations in the pancreatic cancer microenvironment of patients treated with neoadjuvant chemo- and radiotherapy

Farren MR, Sayegh L, Ware MB, Chen HR, Gong J, Liang Y, Krasinskas A, Maithel SK, Zaidi M, Sarmiento JM, Kooby D, Patel P, El-Rayes B, Shaib W, Lesinski GB.

December 10, 2019 / Can J Gastroenterol Hepatol

Expression Analysis of ATP-Binding Cassette Transporters ABCB11 and ABCB4 in Primary Sclerosing Cholangitis and Variety of Pediatric and Adult Cholestatic and Noncholestatic Liver Diseases

Thoeni C et al.,

December 10, 2019 / Oral Oncol.

Prediction of survival of HPV16-negative, p16-negative oral cavity cancer patients using a 13-gene signature: A multicenter study using FFPE samples

Chen C, Lohavanichbutr P, Zhang Y...Wolf G, Dort JC, Wang P

December 6, 2019 / Cancers (Basel)

NF-kappa B Signaling-Related Signatures Are Connected with the Mesenchymal Phenotype of Circulating Tumor Cells in Non-Metastatic Breast Cancer

Popeda M et al.,

December 6, 2019 / Sci Rep

A novel panel of differentially-expressed microRNAs in breast cancer brain metastasis may predict patient survival

Giannoudis A et al.,

December 3, 2019 / Nat Commun

An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironment

Tekpli X et al.,

November 26, 2019 / Clin Cancer Res

The NanoCind® signature is an independent prognosticator of recurrence and death in uterine leiomyosarcomas

Croce S et al.,

November 26, 2019 / J Heart Lung Transplant.

Reverse transcriptase multiplex ligation-dependent probe amplification in endomyocardial biopsies for the diagnosis of cardiac allograft rejection

Adam N et al.,

November 21, 2019 / Liver Cancer

Development of a Novel Inflammation-Based Index for Hepatocellular Carcinoma

Chan SL et al.,

November 20, 2019 / J Natl Cancer Inst

Borderline Estrogen Receptor–Positive Breast Cancers in Black and White Women

Benefield HC, Allott EH, Reeder-Hayes KE, Perou CM, Carey LA, Geradts J, Sun X, Calhoun BC, Troester MA

Previous 1 … 61 62 63 64 65 … 85 Next